Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Lamond Insider Profile
4 Followers
David Lamond, Director at Quince Therapeutics, holds 6.69M shares in Quince Therapeutics (Ticker: QNCX), holds 1.08M shares in Applied Molecular Transport (Ticker: AMTI), holds ― shares in Lucira Health (Ticker: LHDXQ). Most recently, David Lamond Bought ― shares of Quince Therapeutics on Dec 14, 2023 for an estimated value of 69.23K.
Profitable Transactions
1 out of 11 Profitable Transactions
Average Return
-39.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that David Lamond holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Lamond
David Lamond's Trading History
Quince Therapeutics
Dec 14, 2023
Director
Informative Buy
69.23K
$6.14M
Applied Molecular Transport
May 23, 2022
―
Informative Buy
210.85K
$283.39K
Lucira Health
―
―
―
―
List of latest transactions for each holding click on a transaction to see David Lamond's performance on stock
You May Also Like
David Lamond insider profile FAQ
What is the percentage of profitable transactions made by David Lamond?
The percentage of profitable transactions made by David Lamond is 9%.
What is the average return per transaction made by David Lamond?
The average return per transaction made by David Lamond is -39.80%.
What stocks does David Lamond hold?
David Lamond holds: QNCX, AMTI, LHDXQ stocks.
What was David Lamond’s latest transaction?
David Lamond latest transaction was an Informative Buy of $69.23K.
What was David Lamond's most profitable transaction?
David Lamond’s most profitable transaction was an Informative Buy of QNCX stock on June 8, 2020. The return on the trade was 9.50%.
What is David Lamond's role in Quince Therapeutics?
David Lamond's role in Quince Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.